Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

Similar articles for PubMed (Select 10223431)

3.

The influence of baseline symptoms and insight on the therapeutic alliance early in the treatment of schizophrenia.

Wittorf A, Jakobi U, Bechdolf A, Müller B, Sartory G, Wagner M, Wiedemann G, Wölwer W, Herrlich J, Buchkremer G, Klingberg S.

Eur Psychiatry. 2009 May;24(4):259-67. doi: 10.1016/j.eurpsy.2008.12.015. Epub 2009 Feb 5.

PMID:
19200695
4.

Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia?

Couture SM, Roberts DL, Penn DL, Cather C, Otto MW, Goff D.

J Nerv Ment Dis. 2006 Jan;194(1):10-4.

PMID:
16462549
5.

Predictors of the therapeutic alliance in group therapy for individuals with treatment-resistant auditory hallucinations.

Johnson DP, Penn DL, Bauer DJ, Meyer P, Evans E.

Br J Clin Psychol. 2008 Jun;47(Pt 2):171-83. Epub 2007 Sep 26.

PMID:
17900393
6.
7.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

8.

Negative symptoms and poor insight as predictors of the similarity between client and therapist ratings of therapeutic alliance in cognitive behavior therapy for patients with schizophrenia.

Lysaker PH, Davis LW, Buck KD, Outcalt S, Ringer JM.

J Nerv Ment Dis. 2011 Mar;199(3):191-5. doi: 10.1097/NMD.0b013e31820c73eb.

PMID:
21346490
9.

Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?

Wittorf A, Jakobi UE, Bannert KK, Bechdolf A, Müller BW, Sartory G, Wagner M, Wiedemann G, Wölwer W, Herrlich J, Buchkremer G, Klingberg S.

J Nerv Ment Dis. 2010 Jul;198(7):478-85. doi: 10.1097/NMD.0b013e3181e4f526.

PMID:
20611050
10.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
11.

The therapeutic relationship in CBT for psychosis: client, therapist and therapy factors.

Evans-Jones C, Peters E, Barker C.

Behav Cogn Psychother. 2009 Oct;37(5):527-40. doi: 10.1017/S1352465809990269. Epub 2009 Sep 4.

PMID:
19728901
12.
14.

A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.

Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR.

Arch Gen Psychiatry. 2000 Feb;57(2):165-72.

PMID:
10665619
15.

The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.

Misdrahi D, Verdoux H, Lançon C, Bayle F.

Compr Psychiatry. 2009 Mar-Apr;50(2):181-5. doi: 10.1016/j.comppsych.2008.06.010. Epub 2008 Aug 23.

PMID:
19216896
16.

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.

Kane JM, Eerdekens M, Lindenmayer JP, Keith SJ, Lesem M, Karcher K.

Am J Psychiatry. 2003 Jun;160(6):1125-32.

PMID:
12777271
17.

Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment.

Wittorf A, Wiedemann G, Buchkremer G, Klingberg S.

Eur Arch Psychiatry Clin Neurosci. 2008 Feb;258(1):48-58. Epub 2007 Nov 7.

PMID:
17990052
18.

[Effect of olanzapine treatment on cognitive functions in patients with schizophrenia].

Radziwiłłowicz P, Radziwiłłowicz W, Lis J.

Psychiatr Pol. 2002 Nov-Dec;36(6):967-87. Polish.

PMID:
12725025
19.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
20.

Neurocognitive correlates of therapeutic alliance in schizophrenia.

Davis LW, Lysaker PH.

J Nerv Ment Dis. 2004 Jul;192(7):508-10.

PMID:
15232322
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk